Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life
Background: Antiretroviral therapy (ART) started between 7 and 12 weeks of age improves neurodevelopmental outcomes in HIV-infected (HIV+) infants, but the impact of even earlier initiation is not yet described. Objective: We assessed the early neurodevelopment of HIV+ infants who started ART withi...
Saved in:
Main Authors: | Barbara Laughton (Author), Shalena Naidoo (Author), Els F.M.T. Dobbels (Author), Michael J. Boivin (Author), Anita Janse van Rensburg (Author), Richard H. Glashoff (Author), Gert U. van Zyl (Author), Mariana Kruger (Author), Mark F. Cotton (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
When to start antiretroviral therapy in infants and children
by: Mark F Cotton, et al.
Published: (2009) -
Rapid emergence of resistance to antiretroviral treatment after undisclosed prior exposure: A case report
by: Theresa M. Rossouw, et al.
Published: (2019) -
Highly active antiretroviral therapy adherence among HIV-POSITIVE women in Southern Ethiopia
by: Alemayehu Abebe Demissie, et al.
Published: (2024) -
Resources and infrastructure for the delivery of antiretroviral therapy at primary health care facilities in the Free State Province, South Africa
by: Ega Janse van Rensburg-Bonthuyzen, et al.
Published: (2008) -
Taking lead from the community: What do young people living with HIV want us to research?
by: Arish Mudra Rakshasa-Loots, et al.
Published: (2023)